JP2006199609A5 - - Google Patents

Download PDF

Info

Publication number
JP2006199609A5
JP2006199609A5 JP2005012039A JP2005012039A JP2006199609A5 JP 2006199609 A5 JP2006199609 A5 JP 2006199609A5 JP 2005012039 A JP2005012039 A JP 2005012039A JP 2005012039 A JP2005012039 A JP 2005012039A JP 2006199609 A5 JP2006199609 A5 JP 2006199609A5
Authority
JP
Japan
Prior art keywords
kenshoshi
ginkgo
soushi
shitei
shazen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2005012039A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006199609A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2005012039A priority Critical patent/JP2006199609A/ja
Priority claimed from JP2005012039A external-priority patent/JP2006199609A/ja
Publication of JP2006199609A publication Critical patent/JP2006199609A/ja
Publication of JP2006199609A5 publication Critical patent/JP2006199609A5/ja
Pending legal-status Critical Current

Links

JP2005012039A 2005-01-19 2005-01-19 チモシンβ10発現増強剤 Pending JP2006199609A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005012039A JP2006199609A (ja) 2005-01-19 2005-01-19 チモシンβ10発現増強剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005012039A JP2006199609A (ja) 2005-01-19 2005-01-19 チモシンβ10発現増強剤

Publications (2)

Publication Number Publication Date
JP2006199609A JP2006199609A (ja) 2006-08-03
JP2006199609A5 true JP2006199609A5 (https=) 2007-08-02

Family

ID=36957927

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005012039A Pending JP2006199609A (ja) 2005-01-19 2005-01-19 チモシンβ10発現増強剤

Country Status (1)

Country Link
JP (1) JP2006199609A (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011102273A (ja) * 2009-11-11 2011-05-26 Shiseido Co Ltd Tie2活性化剤、血管の成熟化、正常化又は安定化剤、リンパ管安定化剤並びにしわ防止・改善剤及びむくみ改善・予防剤
WO2012131721A1 (en) * 2011-03-31 2012-10-04 Gupta Virendra Prasad Herbal compositions and medicaments thereof for treatment of filariasis
CN102370712B (zh) * 2011-10-25 2013-07-24 豆建全 治疗烧烫伤不留疤痕的中药软膏
CN104435728B (zh) * 2014-11-14 2017-10-31 上海市浦东医院 一种治疗褥疮的外敷中药膏剂及其制备方法和用途
CN104491630A (zh) * 2014-12-05 2015-04-08 山东省立医院 一种治疗褥疮的中药及其制备方法
KR101552813B1 (ko) * 2015-05-18 2015-09-11 충남대학교산학협력단 사군자 추출물을 함유하는 전립선 비대증 예방 또는 치료용 조성물
CN104984078A (zh) * 2015-08-11 2015-10-21 青岛云天生物技术有限公司 一种治疗气血两虚型褥疮的中药组合物及其制备方法
CN106722903A (zh) * 2015-11-24 2017-05-31 哈尔滨墨医生物技术有限公司 一种白薇清热凉血含片及其生产方法
CN110772581A (zh) * 2019-12-24 2020-02-11 哈尔滨圣吉药业股份有限公司 一种复方瓜子金分散片
JP2022171238A (ja) * 2021-04-30 2022-11-11 花王株式会社 組織再生促進剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1160496A (ja) * 1997-08-13 1999-03-02 Advanced Sukin Res Kenkyusho:Kk ヒアルロン酸産生能増強剤
JP2004359732A (ja) * 2003-06-02 2004-12-24 Ryukyu Bio Resource Kaihatsu:Kk 抗酸化剤

Similar Documents

Publication Publication Date Title
CY1120377T1 (el) Στερεη φαρμακευτικη δοσολογικη φαρμακοτεχνικη μορφη που περιεχει λοπιναβιρη
JP2006199609A5 (https=)
JP2004210767A5 (https=)
CA2526598A1 (en) Method for dispensing volatile materials
JP2002542199A5 (https=)
IL189500A (en) 4, 2-Diaminopyrimidines are preserved in position 5, containing pharmaceutical preparations and using them to prepare a drug for the treatment of 3x2p receptor mediated diseases and 2/3 x2p
CL2008000065A1 (es) Compuestos derivados de glicina n-sustituida, inhibidores de hif prolil hidroxilasas; su proceso de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la anemia.
UY27993A1 (es) Derivados de 4-pirrolidino-fenil-bencil eter
AR064201A1 (es) Agente mateante
JP2007523135A5 (https=)
JP2007520565A5 (https=)
CL2007002671A1 (es) Compuestos derivados de octahidro-pirrolo[3,4-c]pirrol; composicion farmaceutica que la comprende; y uso del compuesto en el tratamiento del vih, sida o arc.
JP2003526626A5 (https=)
PE20070618A1 (es) Composicion farmaceutica que contiene rosiglitazona en el tratamiento de alzheimer
JP2005511619A5 (https=)
CL2004001421A1 (es) Composicion farmaceutica que comprende un compuesto derivado de 1,4-dipiperidin-4-il-piperazina; y su uso para la prevencion y/o tratamiento del dolor.
WO2006088814A3 (en) Dosage form and method for sustained release of a substituted pyrazine compound
JP2004026743A5 (https=)
UY29952A1 (es) Composiciones faramacéuticas que comprenden 4-(4-fluoro-2-metil-1h-indol-5-iloxi)-6-metoxi-7-(3-(pirrolidin-1-il)propoxi)quinazolina o una sal farmacéuticamente aceptable del mismo, procesos de preparación y uso
JP2005535670A5 (https=)
CL2006003449A1 (es) Compuestos derivados de n-(fluoro-pirazinil)-fenilsulfonamidas; procedimiento de preparacion; compuesto intermediario; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento del asma.
AR056749A1 (es) Formulaciones de dosificacion oral de ibuprofeno organolepticamente aceptables metodos para su preparacion y uso
ATE439125T1 (de) Fenofibrate tablett und verfahren zur herstellung
JP2005198578A5 (https=)
DE602005026565D1 (de) 5-(2,2-dimethyl-cyclopropyl)-3-methylpent-2-ennitril als geruchs- und geschmacksstoff